Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Danielle Portnik

Use of biomarkers in marketing

Mark Assenti talks about utilisation of biomarkers in marketing is a trend that we have seen growing in 2014 and expect to hear even more about into 2015.

Blue Latitude Health

- PMLiVE

DNA expert: use genes to assess disease risk

Leroy Hood warns that people who opt out of genetic sequencing have their “heads in the sand”

- PMLiVE

UK must embrace genomics or face medicines “dark age”

Life sciences minister George Freeman calls for NHS to embrace new data and technology

Pfizer strikes genetic research deal with 23andMe

Lupus study and research community forms just one part of their collaboration

UK Life Sciences Strategy - one year on

NHS set to deliver ‘world-leading’ genomics centres

Genetics research plans could help create more bespoke medicines

23andMe launches personal genome service in the UK

Mail-order genetic service will cost £125

- PMLiVE

Altering genes on demand

New award-winning research techniques could revolutionise drug discovery

- PMLiVE

Pfizer to work with genetics firm on bowel disease

Agrees deal with 23andMe to research ulcerative colitis and Crohn’s disease

FDA reins in Google-backed genetics company 23andMe

Health-related genetic test service put on hold pending US regulatory review

- PMLiVE

EC appoints group to examine biotech patent laws

Will examine role of patents in genetic engineering

UK Life Sciences Strategy - one year on

UK to introduce DNA mapping for cancer and rare diseases

Will sequence the genomes of up to 100,000 patients within five years

- PMLiVE

Amgen continues spending spree, acquires deCode Genetics

Will pay $415m for Icelandic genetic information firm

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links